Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.
| Current Price | ₹1,414.25 |
|---|---|
| Market Cap | ₹1,890 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 18.4 |
| Return on Equity | 16.79% |
| 52-Week Range | ₹425.80 – ₹1,633.50 |
| Beta (1Y) | 0.04 |
| Dividend Yield | 0.71% |
1. Pharmaceuticals-100%
Venus Remedies Ltd. is trading at ₹1,414.25, with a market capitalisation of ₹1,890 Cr.
Venus Remedies Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Venus Remedies Ltd. has a P/E of 18.4 and a return on equity of 16.79%.